Model A Model A Model B
Variables Hazard ratio (IC) p Hazard ratio (IC) p
Age <50 ans 0.84 (0.31-2.24) NS 0.9 (0.34-2.4) NS
Male gender 2.2 (1.01-4.86) 0.04 * 1.95 (0.9-4.23) NS
Cardiovascular risk factors
Smoking 2.63 (1.18-5.89 0.02* 2.96 (1.34-6.55) 0.007**
Hypertension 0.5 (0.11-2.16) NS 0.38 (0.05-2.88) NS
Diabetes 0.88 (0.3-2.57) NS 0.9 (0.25-3.24) NS
Obesity 1.27 (0.55-3) NS 1.14 (0.51-3.80) NS
Dyslipidemia 0.88 (0.2-3.82) NS 1.22(0.28-5.22) NS
Previous venous thrombosis 2.19 (1.01-4.76) 0.04* 4,11 (1.82-9.32) 0.001**
Previous cardiovascular events 3.32 (1-11.2) 0.04* 4.23 (1.24-14.45) 0.02*
Family history of venous thrombosis 1.19 (0.44-3.19) NS 0.87 (0.33-2.3) NS
Thrombosis circomstunces
Idiopathic 2,7 (1.03-7.36) 0.04* 2.24(0.82-6.07) NS
Secondary to transient risk factor Referent Referent
Persistant risk factor 4.92 (1.64-14.74) 0.004** 2.57 (0.88-7.51) NS
Localizations
Proximal deep venous thrombosis 0.95 (0.31-2.9) NS 1.01 (0.32-3.14) NS
1.93 (0.86-4.35)§ NS 3.2 (1.36-7.54) § 0.008**
Pulmonary embolism 0.19 (0.03-1,07) NS 0.37(0.08-1.69) NS
Distal deep venous thrombosis referent referent
Treatment duration< 6 mois 0.6 (0.14-2.74) NS 0.28(0.06-1.24) NS
Indefinite treatment duration 0.97 (0.41-2.32) NS - -
Post phlebitic syndrome 2.68 (1.23-5.82) 0,01* 3.45 (1.59-7.48) 0.002**
Thrombophilia
1.45 (0.51-4.07)
0,49
1.31 (0.47-3.63)
0.6